Mitchell Chan

Mitchell Chan

EVP, Chief Financial OfficeratRegenxbio· In the 2024 proxy

Pay in FY2024Regenxbio stock -56.9% the same year

Mitchell Chan was paid $3.2M in FY2024 (Dec). Regenxbio stock fell 56.9% that year.

Pay$100 in the stock at the end of FY23 → $43
Pay is from the Summary Compensation Table of each Regenxbio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. RegenxbioPublic company · 2 yr
    • EVP, Chief Financial Officer2024 – Present · 2 yrStock in role -61%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?